Lift in Mortgage Cure Rates May Bode Well for FHA Recovery

Why It Matters

Higher cure rates signal that distressed borrowers are beginning to recover, easing pressure on servicers and investors, while lingering delinquency and foreclosure levels highlight ongoing credit risk in the housing market.

Key Takeaways

• April cure rate exceeds 62,000, up from 42,000 average
• FHA rule change lifts serious delinquencies while cures double
• Overall delinquency rate sits at 3.35%, up 13 bps YoY
• Foreclosure starts rise to 37,000, highest April since pandemic
• Seasonal tax refunds and bonuses help stabilize mortgage performance

Pulse Analysis

The surge in mortgage cures this April reflects a tentative rebound in a market still grappling with the Federal Housing Administration’s post‑pandemic policy shift. By relaxing assistance rules, the FHA aimed to reduce borrower hardship, yet the change also inflated the pool of loans classified as seriously delinquent. ICE’s data shows cures from 90‑plus‑day arrears more than doubled, suggesting that the new framework is beginning to work, but the absolute volume remains 15‑20% below the projected Q3 2025 average, underscoring a partial, not complete, recovery.

Beyond cure metrics, broader credit indicators paint a mixed picture. The delinquency rate steadied at 3.35%, a modest rise over the prior year but still below pre‑pandemic peaks. Foreclosure activity, however, ticked upward with 37,000 new starts—April’s highest since 2020—while foreclosure sales rose 22% year‑over‑year, hinting at lingering stress among the most vulnerable borrowers. Prepayment rates slipped to 0.92% as higher interest rates dampened refinancing demand, further limiting relief pathways for distressed homeowners.

For lenders, investors, and policymakers, these trends signal both opportunities and cautions. Servicers can leverage the improving cure rates to trim loss reserves, yet must remain vigilant as serious delinquencies stay elevated. Investors may reassess risk premiums on mortgage‑backed securities, factoring in the interplay between policy‑driven cure improvements and seasonal boosts from tax refunds or bonuses. Looking ahead, the June‑onward data window will be critical to determine whether the current uplift is a seasonal blip or the start of a sustained normalization in the FHA‑backed loan portfolio.